Literature DB >> 18930526

Emergence of chronic non-communicable diseases in China.

Gonghuan Yang1, Lingzhi Kong, Wenhua Zhao, Xia Wan, Yi Zhai, Lincoln C Chen, Jeffrey P Koplan.   

Abstract

China has experienced an epidemiological transition shifting from the infectious to the chronic diseases in much shorter time than many other countries. The pace and spread of behavioural changes, including changing diets, decreased physical activity, high rates of male smoking, and other high risk behaviours, has accelerated to an unprecedented degree. As a result, the burden of chronic diseases, preventable morbidity and mortality, and associated health-care costs could now increase substantially. China already has 177 million adults with hypertension; furthermore, 303 million adults smoke, which is a third of the world's total number of smokers, and 530 million people in China are passively exposed to second-hand smoke. The prevalence of overweight people and obesity is increasing in Chinese adults and children, because of dietary changes and reduced physical activity. Emergence of chronic diseases presents special challenges for China's ongoing reform of health care, given the large numbers who require curative treatment and the narrow window of opportunity for timely prevention of disease.

Entities:  

Mesh:

Year:  2008        PMID: 18930526     DOI: 10.1016/S0140-6736(08)61366-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  232 in total

1.  Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial.

Authors:  Tazeen H Jafar; Muhammad Islam; Rasool Bux; Neil Poulter; Juanita Hatcher; Nish Chaturvedi; Shah Ebrahim; Peter Cosgrove
Journal:  Circulation       Date:  2011-09-19       Impact factor: 29.690

2.  Health disparities among the western, central and eastern rural regions of China after a decade of health promotion and disease prevention programming.

Authors:  Xi-Fan Zhang; Xiang-Yang Tian; Yu-Lan Cheng; Zhan-Chun Feng; Liang Wang; Jodi Southerland
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

3.  Age-related differences in cigarette smoke extract-induced H2O2 production by lung endothelial cells.

Authors:  Charles A Downs; David W Montgomery; Carrie J Merkle
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

4.  The risk of success: cultural determinants of chronic disease and sexually transmitted infections among urban Chinese men.

Authors:  Elanah Uretsky
Journal:  Health Promot Int       Date:  2010-11-18       Impact factor: 2.483

5.  Age, period and cohort effects on adult body mass index and overweight from 1991 to 2009 in China: the China Health and Nutrition Survey.

Authors:  Lindsay M Jaacks; Penny Gordon-Larsen; Elizabeth J Mayer-Davis; Linda S Adair; Barry Popkin
Journal:  Int J Epidemiol       Date:  2013-06-14       Impact factor: 7.196

6.  Effects of Preoperative Risk Stratification on Direct In-hospital Costs for Chinese Patients with Coronary Artery Bypass Graft: A Single Center Analysis.

Authors:  Mei Yang; Jia Hao; Zhao Jian; Ying-Bin Xiao; Lai-Xin Zhou
Journal:  Curr Med Sci       Date:  2018-12-07

7.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

8.  Patients' experiences in different models of community health centers in southern China.

Authors:  Harry H X Wang; Samuel Y S Wong; Martin C S Wong; Xiao Lin Wei; Jia Ji Wang; Donald K T Li; Jin Ling Tang; Gemma Y Gao; Sian M Griffiths
Journal:  Ann Fam Med       Date:  2013 Nov-Dec       Impact factor: 5.166

9.  Socio-economic disparities in mortality among the elderly in China.

Authors:  Weixiang Luo; Yu Xie
Journal:  Popul Stud (Camb)       Date:  2014-08-06

10.  Convergence of non-communicable and infectious diseases in low- and middle-income countries.

Authors:  Justin V Remais; Guang Zeng; Guangwei Li; Lulu Tian; Michael M Engelgau
Journal:  Int J Epidemiol       Date:  2012-10-13       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.